Therapeutic Area:
Oncology
Products List
Comprehensive range of trusted cancer medicines supporting prevention, treatment, and ongoing care — from first-line treatments to the most advanced therapies.
| Brand Name |
Generic Name | Strength | Form |
|---|---|---|---|
|
AbiraGet
|
Abiraterone Acetate | 250 mg | Tablet |
|
Brand Name
AbiraGet
Generic Name
Abiraterone Acetate
Strength
250 mg
Form
Tablet
Pharmacologic Category
Endocrine Therapy (Hormone Antagonist)
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
AnaGaling
|
Anastrozole | 1 mg | Film-Coated Tablet |
|
Brand Name
AnaGaling
Generic Name
Anastrozole
Strength
1 mg
Form
Film-Coated Tablet
Pharmacologic Category
Antineoplastic (Aromatase Inhibitors)
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
BendaGet
|
Bendamustine | 100 mg | Lyophilized Powder for Concentrate Solution for IV Infusion |
|
Brand Name
BendaGet
Generic Name
Bendamustine
Strength
100 mg
Form
Lyophilized Powder for Concentrate Solution for IV Infusion
Pharmacologic Category
Antineoplastic
Clinical Category
Oncology / Hematology
Therapeutic Area
Oncology
|
|||
|
BleoGet
|
Bleomycin | 15 units | Lyophilized Powder for Injection (IM/IV/SC) |
|
Brand Name
BleoGet
Generic Name
Bleomycin
Strength
15 units
Form
Lyophilized Powder for Injection (IM/IV/SC)
Pharmacologic Category
Antineoplastic (Cytotoxic Antibiotic)
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
BorteGet
|
Bortezomib | 3.5 mg | Lyophilized Powder for Solution for Injection (I.V. / S.C.) |
|
Brand Name
BorteGet
Generic Name
Bortezomib
Strength
3.5 mg
Form
Lyophilized Powder for Solution for Injection (I.V. / S.C.)
Pharmacologic Category
Antineoplastic
Clinical Category
Oncology / Hematology
Therapeutic Area
Oncology
|
|||
|
CapeGet
|
Capecitabine | 500 mg | Film-Coated Tablet |
|
Brand Name
CapeGet
Generic Name
Capecitabine
Strength
500 mg
Form
Film-Coated Tablet
Pharmacologic Category
Antineoplastic
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
CarboGet
|
Carboplatin | 150 mg / 15 mL (10 mg / mL) | Solution for Intravenous Infusion |
|
Brand Name
CarboGet
Generic Name
Carboplatin
Strength
150 mg / 15 mL (10 mg / mL)
Form
Solution for Intravenous Infusion
Pharmacologic Category
Anti-neoplastic agent
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
Carboget
|
Carboplatin | 450 mg / 45 mL | Solution for Intravenous Infusion |
|
Brand Name
Carboget
Generic Name
Carboplatin
Strength
450 mg / 45 mL
Form
Solution for Intravenous Infusion
Pharmacologic Category
Anti-neoplastic agent
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
CytaGet
|
Cytarabine | 100 mg/mL (500 mg/5 mL) | Solution for Injection (IV/SC) |
|
Brand Name
CytaGet
Generic Name
Cytarabine
Strength
100 mg/mL (500 mg/5 mL)
Form
Solution for Injection (IV/SC)
Pharmacologic Category
Antineoplastic
Clinical Category
therapeutic_area: Oncology
Therapeutic Area
Oncology
|
|||
|
CytaGet
|
Cytarabine | 100 mg/mL | Solution for Injection (IV/SC) |
|
Brand Name
CytaGet
Generic Name
Cytarabine
Strength
100 mg/mL
Form
Solution for Injection (IV/SC)
Pharmacologic Category
Antineoplastic
Clinical Category
therapeutic_area: Oncology
Therapeutic Area
Oncology
|
|||
|
DoseGet-120
|
Docetaxel | 120 mg / 3 mL | Concentrate Solution for IV Infusion |
|
Brand Name
DoseGet-120
Generic Name
Docetaxel
Strength
120 mg / 3 mL
Form
Concentrate Solution for IV Infusion
Pharmacologic Category
Antineoplastic
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
DoseGet-20
|
Docetaxel | 20 mg / 0.5 mL | Concentrate Solution for IV Infusion |
|
Brand Name
DoseGet-20
Generic Name
Docetaxel
Strength
20 mg / 0.5 mL
Form
Concentrate Solution for IV Infusion
Pharmacologic Category
Antineoplastic (Taxane)
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
DoseGet-80
|
Docetaxel | 40 mg / mL | Concentrate Solution for IV Infusion |
|
Brand Name
DoseGet-80
Generic Name
Docetaxel
Strength
40 mg / mL
Form
Concentrate Solution for IV Infusion
Pharmacologic Category
Antineoplastic (Taxane)
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
FluoroGet-500
|
Fluorouracil | 50mg/mL | Solution for Injection (IV Infusion) |
|
Brand Name
FluoroGet-500
Generic Name
Fluorouracil
Strength
50mg/mL
Form
Solution for Injection (IV Infusion)
Pharmacologic Category
Antineoplastic Agent (Pyrimidine Analogue)
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
GemGet
|
Gemcitabine | 1 g | Lyophilized Powder for Injection (IV) |
|
Brand Name
GemGet
Generic Name
Gemcitabine
Strength
1 g
Form
Lyophilized Powder for Injection (IV)
Pharmacologic Category
Antineoplastic Agent (Pyrimidine analogue)
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
GemGet 200
|
Gemcitabine | 200 mg | Lyophilized Powder for Injection (IV) |
|
Brand Name
GemGet 200
Generic Name
Gemcitabine
Strength
200 mg
Form
Lyophilized Powder for Injection (IV)
Pharmacologic Category
Antineoplastic Agent
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
HydroxyGet
|
Hydroxyurea | 500 mg | Capsule |
|
Brand Name
HydroxyGet
Generic Name
Hydroxyurea
Strength
500 mg
Form
Capsule
Pharmacologic Category
Antineoplastic Agent
Clinical Category
Oncology / Hematology
Therapeutic Area
Oncology
|
|||
|
Imonib-100
|
Imatinib | 100 mg | Film-Coated Tablet |
|
Brand Name
Imonib-100
Generic Name
Imatinib
Strength
100 mg
Form
Film-Coated Tablet
Pharmacologic Category
Antineoplastic Agent (Protein kinase inhibitor)
Clinical Category
Oncology / Hematology
Therapeutic Area
Oncology
|
|||
|
Lapanib
|
Lapatinib | 250 mg | Film-Coated Tablet |
|
Brand Name
Lapanib
Generic Name
Lapatinib
Strength
250 mg
Form
Film-Coated Tablet
Pharmacologic Category
Antineoplastic Agent (Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitor
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
LetroGet
|
Letrozole | 2.5 mg | Film-Coated Tablet |
|
Brand Name
LetroGet
Generic Name
Letrozole
Strength
2.5 mg
Form
Film-Coated Tablet
Pharmacologic Category
Antineoplastic (Aromatase Inhibitor)
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
MethoGet-500
|
Methotrexate | 100mg/mL | Solution for Injection |
|
Brand Name
MethoGet-500
Generic Name
Methotrexate
Strength
100mg/mL
Form
Solution for Injection
Pharmacologic Category
Antineoplastic Agent (Folic Acid Analogue)
Clinical Category
therapeutic_area: Oncology
Therapeutic Area
Oncology
|
|||
|
OndaGet
|
Ondansetron (as Hydrochloride) | 8 mg | Tablet |
|
Brand Name
OndaGet
Generic Name
Ondansetron (as Hydrochloride)
Strength
8 mg
Form
Tablet
Pharmacologic Category
Antiemetic/ Antinauseant
Clinical Category
Oncology / Hematology / Anesthesiology
Therapeutic Area
Oncology
|
|||
|
OxaliGet
|
Oxaliplatin | 2mg/mL (100mg/50mL) | Solution for IV Infusion |
|
Brand Name
OxaliGet
Generic Name
Oxaliplatin
Strength
2mg/mL (100mg/50mL)
Form
Solution for IV Infusion
Pharmacologic Category
Antineoplastic
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
OxaliGet-50
|
Oxaliplatin | 2mg/mL (50mg/25mL) | Solution for IV Infusion |
|
Brand Name
OxaliGet-50
Generic Name
Oxaliplatin
Strength
2mg/mL (50mg/25mL)
Form
Solution for IV Infusion
Pharmacologic Category
Antineoplastic
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
PacliGet
|
Paclitaxel | 6 mg/mL (100mg/16.7mL) | Solution for IV Infusion |
|
Brand Name
PacliGet
Generic Name
Paclitaxel
Strength
6 mg/mL (100mg/16.7mL)
Form
Solution for IV Infusion
Pharmacologic Category
Antineoplastic Agent
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
PacliGet-260
|
Paclitaxel | 6mg/mL (260 mg / 43.4 mL) | Solution for Injection (IV Infusion) |
|
Brand Name
PacliGet-260
Generic Name
Paclitaxel
Strength
6mg/mL (260 mg / 43.4 mL)
Form
Solution for Injection (IV Infusion)
Pharmacologic Category
Antineoplastic Agent (Taxane)
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
PacliGet-300
|
Paclitaxel | 6mg/mL (300 mg / 50mL) | Solution for IV Injection |
|
Brand Name
PacliGet-300
Generic Name
Paclitaxel
Strength
6mg/mL (300 mg / 50mL)
Form
Solution for IV Injection
Pharmacologic Category
Antineoplastic
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
PemiGet
|
Pemetrexed | 500 mg | Lyophilized Powder for Concentrate Solution for IV Infusion |
|
Brand Name
PemiGet
Generic Name
Pemetrexed
Strength
500 mg
Form
Lyophilized Powder for Concentrate Solution for IV Infusion
Pharmacologic Category
Antineoplastic agent (Folic acid Analogue)
Clinical Category
Oncology / Hematology
Therapeutic Area
Oncology
|
|||
|
SoraGet
|
Sorafenib | 200 mg | Film-Coated Tablet |
|
Brand Name
SoraGet
Generic Name
Sorafenib
Strength
200 mg
Form
Film-Coated Tablet
Pharmacologic Category
Antineoplastic Agent
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
TemoGet
|
Temozolomide | 100 mg | Capsule |
|
Brand Name
TemoGet
Generic Name
Temozolomide
Strength
100 mg
Form
Capsule
Pharmacologic Category
Antineoplastic
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
VincriGet
|
Vincristine | 1 mg / ml | Solution for Injection (IV) |
|
Brand Name
VincriGet
Generic Name
Vincristine
Strength
1 mg / ml
Form
Solution for Injection (IV)
Pharmacologic Category
Antineoplastic Agent
Clinical Category
Oncology
Therapeutic Area
Oncology
|
|||
|
ZoloGet
|
Zoledronic Acid | 4 mg | Lyophilized Powder for IV Infusion |
|
Brand Name
ZoloGet
Generic Name
Zoledronic Acid
Strength
4 mg
Form
Lyophilized Powder for IV Infusion
Pharmacologic Category
Drug Affecting Bone Structure & Mineralization (Biphosphonates)
Clinical Category
Oncology/Hematology
Therapeutic Area
Oncology
|
|||
